Central noradrenergic control of blood pressure

Use of losartan in the treatment of hypertensive patients with a history of cough induced by angiotensin-converting enzyme inhibitors.

Clinical therapeutics·1998

Three candidate genes and angiotensin-converting enzyme inhibitor-related cough: a pharmacogenetic analysis.

Hypertension (Dallas, Tex. : 1979)·1998

Comparative antihypertensive effects of losartan 50 mg and losartan 50 mg titrated to 100 mg in patients with essential hypertension.

Blood pressure·1997

An inpatient trial of the safety and efficacy of losartan compared with placebo and enalapril in patients with essential hypertension.

Cardiovascular drugs and therapy·1996

Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.

Archives of internal medicine·1996

Comparative effects of combination drug therapy regimens commencing with either losartan potassium, an angiotensin II receptor antagonist, or enalapril maleate for the treatment of severe hypertension.

Journal of hypertension·1996

Making Drug Dosing Decisions Based on Therapeutic Monitoring.

Annual review of pharmacology and toxicology·2026

Pharmacoexposomics: The Environmental Complement to Pharmacogenomics to Advance Precision Medicine.

Annual review of pharmacology and toxicology·2026

Nonaddictive Analgesia: New Approaches That Target the Hodgkin-Huxley NaV/KV Dyad.

Annual review of pharmacology and toxicology·2026

Beyond Catalytic Inhibition: The Evolving Landscape of PARP Pharmacology.

Annual review of pharmacology and toxicology·2026

Vesicular Monoamine Transporters at the Crossroads of Structure and Function: Advances, Challenges, and Future Perspectives.

Annual review of pharmacology and toxicology·2026

The Pharmacology of CAR T Cell Therapy for Autoimmune Disease.

Annual review of pharmacology and toxicology·2026

Targeting the NLRP3 inflammasome pathway associated with neuroinflammation mediated Alzheimer's disease: pre-clinical and clinical status of emerging therapeutics.

Expert opinion on therapeutic targets·2026

Relationship between retinal nerve fibre thickness, suprasellar extension and post-operative visual outcome in pituitary macroadenoma.

International journal of ophthalmology·2026

Closed-loop bioelectronic block of stellate ganglia reduces neurotransmitter release and improves recovery following programmed ventricular pacing.

Frontiers in bioengineering and biotechnology·2026

Serum IL-6 and functional outcome after endovascular therapy: the mediating role of infarct volume growth in acute ischemic stroke.

Frontiers in immunology·2026

NR1D1-Mediated Suppression of JAK1/STAT3 Signaling Contributes to the Therapeutic Effects of Triptolide in Rheumatoid Arthritis.

Mediators of inflammation·2026

Small RNA sequencing identifies T cell-derived tsRNAs as novel biomarkers for diagnosis and clinical assessment of rheumatoid arthritis.

International immunopharmacology·2026

Related Experiment Videos

Central noradrenergic control of blood pressure

Related Concept Videos

Use of losartan in the treatment of hypertensive patients with a history of cough induced by angiotensin-converting enzyme inhibitors.

Three candidate genes and angiotensin-converting enzyme inhibitor-related cough: a pharmacogenetic analysis.

Comparative antihypertensive effects of losartan 50 mg and losartan 50 mg titrated to 100 mg in patients with essential hypertension.

An inpatient trial of the safety and efficacy of losartan compared with placebo and enalapril in patients with essential hypertension.

Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.

Comparative effects of combination drug therapy regimens commencing with either losartan potassium, an angiotensin II receptor antagonist, or enalapril maleate for the treatment of severe hypertension.

Making Drug Dosing Decisions Based on Therapeutic Monitoring.

Pharmacoexposomics: The Environmental Complement to Pharmacogenomics to Advance Precision Medicine.

Nonaddictive Analgesia: New Approaches That Target the Hodgkin-Huxley NaV/KV Dyad.

Beyond Catalytic Inhibition: The Evolving Landscape of PARP Pharmacology.

Vesicular Monoamine Transporters at the Crossroads of Structure and Function: Advances, Challenges, and Future Perspectives.

The Pharmacology of CAR T Cell Therapy for Autoimmune Disease.

Targeting the NLRP3 inflammasome pathway associated with neuroinflammation mediated Alzheimer's disease: pre-clinical and clinical status of emerging therapeutics.

Relationship between retinal nerve fibre thickness, suprasellar extension and post-operative visual outcome in pituitary macroadenoma.

Closed-loop bioelectronic block of stellate ganglia reduces neurotransmitter release and improves recovery following programmed ventricular pacing.

Serum IL-6 and functional outcome after endovascular therapy: the mediating role of infarct volume growth in acute ischemic stroke.

NR1D1-Mediated Suppression of JAK1/STAT3 Signaling Contributes to the Therapeutic Effects of Triptolide in Rheumatoid Arthritis.

Small RNA sequencing identifies T cell-derived tsRNAs as novel biomarkers for diagnosis and clinical assessment of rheumatoid arthritis.

Related Experiment Videos

Central noradrenergic control of blood pressure

Related Concept Videos

Related Articles